Author:
Awwad O.,Coperchini F.,Pignatti P.,Denegri M.,Massara S.,Croce L.,Di Buduo C. A.,Abbonante V.,Balduini A.,Chiovato L.,Rotondi M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference45 articles.
1. Galiñanes M, Bullough D, Mullane KM, Hearse DJ (1992) Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart. Circulation 86:589–597
2. Pokrywka A, Cholbinski P, Kaliszewski P, Kowalczyk K, Konczak D, Zembron-Lacny A (2014) Metabolic modulators of the exercise response: doping control analysis of an agonist of the peroxisome proliferator-activated receptor δ (GW501516) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). J Physiol Pharmacol 65:469–476
3. Cazarin JM, Coelho RG, Hecht F, Andrade BM, Carvalho DP (2016) 5′-AMP-activated protein kinase regulates papillary (TPC-1 and BCPAP) thyroid cancer cell survival, migration, invasion, and epithelial-to-mesenchymal transition. Thyroid 26:933–942
4. Choi HJ, Kim TY, Chung N et al (2011) The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside. J Endocrinol 211:79–85
5. Wright C, Iyer AKV, Kaushik V, Azad N (2017) Anti-tumorigenic potential of a novel Orlistat-AICAR combination in prostate cancer cells. J Cell Biochem 118(11):3834–3845
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献